Insulin-like growth factor binding protein-1 is a long-term predictor of heart failure in survivors of a first acute myocardial infarction and population controls

International Journal of Cardiology

Volumn 138, Issue 1, 2010, Pages 50-55

  Janszky, Imre ^a,b   Hallqvist, Johan ^a,c   Ljung, Rickard ^a,d   Hammar, Niklas ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Stockholm Centre of Public Health   (Sweden)

^d CENTRE FOR EPIDEMIOLOGY   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

Acute myocardial infarction; Heart failure; IGFBP 1; Prognosis

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STROKE; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 70749110057     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.08.003     Document Type: Article

References (23)

1. Bayes-Genis A., Conover C.A., and Schwartz R.S. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86 2 (2000) 125-130
2. Delafontaine P., Song Y.H., and Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24 3 (2004) 435-444
3. Heald A.H., Cruickshank J.K., Riste L.K., et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44 3 (2001) 333-339
4. Janssen J.A., Stolk R.P., Pols H.A., Grobbee D.E., and Lamberts S.W. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 18 2 (1998) 277-282
5. Hellenius M.L., Brismar K.E., Berglund B.H., and de Faire U.H. Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med 238 2 (1995) 121-130
6. Laughlin G.A., Barrett-Connor E., Criqui M.H., and Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study. J Clin Endocrinol Metab 89 1 (2004) 114-120
7. Kaplan R.C., McGinn A.P., Pollak M.N., et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 92 4 (2007) 1319-1325
8. Harrela M., Qiao Q., Koistinen R., et al. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 34 3 (2002) 144-149
9. Kalme T., Seppala M., Qiao Q., et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 90 3 (2005) 1550-1556
10. Wallander M., Norhammar A., Malmberg K., Ohrvik J., Ryden L., and Brismar K. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. Diabetes Care 30 9 (2007) 2343-2348
11. Anwar A., Gaspoz J.M., Pampallona S., et al. Effect of congestive heart failure on the insulin-like growth factor-1 system. Am J Cardiol 90 12 (2002) 1402-1405
12. Dean R., Edmondson S.R., Burrell L.M., and Bach L.A. Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction. J Histochem Cytochem 47 5 (1999) 649-660
13. Saeki H., Hamada M., and Hiwada K. Circulating levels of insulin-like growth factor-1 and its binding proteins in patients with hypertrophic cardiomyopathy. Circ J 66 7 (2002) 639-644
14. Reuterwall C., Hallqvist J., Ahlbom A., et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J Intern Med 246 2 (1999) 161-174
15. Bennet A.M., Brismar K., Hallqvist J., Reuterwall C., and De Faire U. The risk of myocardial infarction is enhanced by a synergistic interaction between serum insulin and smoking. Eur J Endocrinol 147 5 (2002) 641-647
16. Povoa G., Roovete A., and Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 107 4 (1984) 563-570
17. Hammar N., Nerbrand C., Ahlmark G., et al. Identification of cases of myocardial infarction: hospital discharge data and mortality data compared to myocardial infarction community registers. Int J Epidemiol 20 1 (1991) 114-120
18. Rosen M. National Health Data Registers: a Nordic heritage to public health. Scand J Public Health 30 (2002) 81-85
19. Schaufelberger M.S.K., Koster M., Rosen M., and Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 25 (2004) 300-307
20. Ingelsson E., Arnlov J., Sundstrom J., and Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7 5 (2005) 787-791
21. Rothman K. Modern epidemiology (1986), Little, Brown and Company, Boston/Toronto
22. McGowan B.S., Ciccimaro E.F., Chan T.O., and Feldman A.M. The balance between pro-apoptotic and anti-apoptotic pathways in the failing myocardium. Cardiovasc Toxicol 3 3 (2003) 191-206
23. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150